Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357252 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357254 (2-(5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357250 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357246 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357254 (2-(5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357254 (2-(5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357249 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357252 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357246 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357250 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357250 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357249 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357246 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357249 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357247 (Methyl 5-(5-amino-4-(1H-indole-2-carbonyl)-1H-pyra...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 2 (Homo sapiens (Human)) | BDBM357248 (Ethyl 5-(5-Amino-4-(1H-indole-2-carbonyl)-1H-pyraz...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357252 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357247 (Methyl 5-(5-amino-4-(1H-indole-2-carbonyl)-1H-pyra...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 75.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357247 (Methyl 5-(5-amino-4-(1H-indole-2-carbonyl)-1H-pyra...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >100 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357254 (2-(5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 135 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357253 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357250 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 308 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357252 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357246 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357249 ((5-amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357251 ((5-Amino-1-(2-cyclopropyl-1H-benzo[d]imidazol-5-yl...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 3 (Homo sapiens (Human)) | BDBM357248 (Ethyl 5-(5-Amino-4-(1H-indole-2-carbonyl)-1H-pyraz...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357247 (Methyl 5-(5-amino-4-(1H-indole-2-carbonyl)-1H-pyra...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 1 (Homo sapiens (Human)) | BDBM357248 (Ethyl 5-(5-Amino-4-(1H-indole-2-carbonyl)-1H-pyraz...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Fibroblast growth factor receptor 4 (Homo sapiens (Human)) | BDBM357248 (Ethyl 5-(5-Amino-4-(1H-indole-2-carbonyl)-1H-pyraz...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Zhejiang Hisun Pharmaceutical Co., Ltd. US Patent | Assay Description The following assay was used to determine the inhibition rate of the preferred compounds of the present invention to the kinase activity of the recom... | US Patent US10214515 (2019) BindingDB Entry DOI: 10.7270/Q22J6F46 | |||||||||||
More data for this Ligand-Target Pair |